Immunovant, Inc. (IMVT)

NASDAQ: IMVT · Real-Time Price · USD

14.72

-0.35 (-2.32%)

At close: Apr 25, 2025, 4:00 PM

14.80

+0.08 (0.54%)

Pre-market: Apr 28, 2025, 8:45 AM EDT

Immunovant Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Apr '25 Apr 25, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2018 - 2019
Market Capitalization	2,500	4,694	2,005	641	1,571	851	Upgrade
Market Cap Growth	-40.34%	134.16%	212.60%	-59.19%	84.72%	-	Upgrade
Enterprise Value	2,126	4,004	1,574	117	1,153	730	Upgrade
Last Close Price	14.72	32.31	15.51	5.51	16.04	15.56	Upgrade
PB Ratio	6.15	7.60	5.53	1.37	4.01	9.04	Upgrade
P/TBV Ratio	7.09	7.60	5.53	1.37	4.01	9.04	Upgrade
Debt / Equity Ratio	0	0	0.00	0.01	0.01	0.03	Upgrade
Quick Ratio	5.52	13.18	8.72	11.38	21.38	6.76	Upgrade
Current Ratio	6.04	13.70	9.34	11.52	21.79	7.12	Upgrade
Return on Equity (ROE)	-74.17%	-52.91%	-50.69%	-36.39%	-44.25%	-130.93%	Upgrade
Return on Assets (ROA)	-44.73%	-31.50%	-28.26%	-21.02%	-25.90%	-64.70%	Upgrade
Return on Capital (ROIC)	-49.07%	-34.41%	-31.14%	-22.49%	-27.46%	-76.22%	Upgrade
Earnings Yield	-15.31%	-5.52%	-10.52%	-24.44%	-6.84%	-7.80%	Upgrade
FCF Yield	-13.02%	-4.57%	-9.40%	-16.59%	-5.32%	-6.28%	Upgrade
Buyback Yield / Dilution	-9.00%	-12.21%	-12.21%	-24.98%	-103.14%	-94.85%	Upgrade

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q